{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:01:17Z","timestamp":1781650877715,"version":"3.54.5"},"reference-count":137,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,26]],"date-time":"2024-05-26T00:00:00Z","timestamp":1716681600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.biopha.2024.116829","type":"journal-article","created":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T18:54:31Z","timestamp":1717095271000},"page":"116829","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Targeting Nrf2 signaling pathways in the role of bladder cancer: From signal network to targeted therapy"],"prefix":"10.1016","volume":"176","author":[{"given":"Liang","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-fen","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-jian","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang-huan","family":"Xiahou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.biopha.2024.116829_bib1","first-page":"87","article-title":"Global cancer statistics, 2012 [J]","volume":"65","author":"TORRE","year":"2015","journal-title":"CA: a Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.biopha.2024.116829_bib2","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries [J]","volume":"71","author":"SUNG","year":"2021","journal-title":"CA: a Cancer J. Clin."},{"issue":"6","key":"10.1016\/j.biopha.2024.116829_bib3","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1159\/000495956","article-title":"Loss of tumor suppressor gene function in human cancer: an overview [J]","volume":"51","author":"WANG","year":"2018","journal-title":"Cell Physiol. Biochem"},{"issue":"4","key":"10.1016\/j.biopha.2024.116829_bib4","first-page":"180","article-title":"Cancer and oncogenesis] [J]","volume":"115","author":"BLOEMENA","year":"2008","journal-title":"Ned. Tijdschr. voor Tandheelkd."},{"issue":"10364","key":"10.1016\/j.biopha.2024.116829_bib5","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/S0140-6736(22)01188-6","article-title":"Current best practice for bladder cancer: a narrative review of diagnostics and treatments [J]","volume":"400","author":"COMP\u00e9RAT","year":"2022","journal-title":"Lancet (Lond., Engl. )"},{"issue":"3","key":"10.1016\/j.biopha.2024.116829_bib6","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00345-009-0383-3","article-title":"The present and future burden of urinary bladder cancer in the world [J]","volume":"27","author":"PLOEG","year":"2009","journal-title":"World J. Urol."},{"key":"10.1016\/j.biopha.2024.116829_bib7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.canlet.2020.04.023","article-title":"Non-coding RNA in bladder cancer [J]","volume":"485","author":"LI","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2024.116829_bib8","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.semcancer.2020.04.006","article-title":"Repurposing of drugs: An attractive pharmacological strategy for cancer therapeutics [J]","volume":"68","author":"KIRTONIA","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.biopha.2024.116829_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120752","article-title":"Naringenin: A potential flavonoid phytochemical for cancer therapy [J]","volume":"305","author":"MOTALLEBI","year":"2022","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.biopha.2024.116829_bib10","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nrc.2017.17","article-title":"Prospects for combining targeted and conventional cancer therapy with immunotherapy [J]","volume":"17","author":"GOTWALS","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2024.116829_bib11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1570163812666150602144310","article-title":"Targeted cancer therapy: the next generation of cancer treatment [J]","volume":"12","author":"BAUDINO","year":"2015","journal-title":"Curr. Drug Discov. Technol."},{"issue":"5","key":"10.1016\/j.biopha.2024.116829_bib12","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2174\/138920212801619232","article-title":"Bladder cancer: a simple model becomes complex [J]","volume":"13","author":"DI PIERRO","year":"2012","journal-title":"Curr. Genom."},{"issue":"2","key":"10.1016\/j.biopha.2024.116829_bib13","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1590\/S1415-47572013005000015","article-title":"Bioinformatics analysis of the gene expression profile in Bladder carcinoma [J]","volume":"36","author":"XIAO","year":"2013","journal-title":"Genet. Mol. Biol."},{"key":"10.1016\/j.biopha.2024.116829_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemosphere.2023.139716","article-title":"Low-dose antimony exposure promotes prostate cancer proliferation by inhibiting ferroptosis via activation of the Nrf2-SLC7A11-GPX4 pathway [J]","volume":"339","author":"SHI","year":"2023","journal-title":"Chemosphere"},{"issue":"12","key":"10.1016\/j.biopha.2024.116829_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12123609","article-title":"NRF2 and the ambiguous consequences of its activation during initiation and the subsequent stages of tumourigenesis [J]","volume":"12","author":"ROBERTSON","year":"2020","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.biopha.2024.116829_bib16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s12276-021-00663-2","article-title":"Oncogenic E3 ubiquitin ligase NEDD4 binds to KLF8 and regulates the microRNA-132\/NRF2 axis in bladder cancer [J]","volume":"54","author":"MAO","year":"2022","journal-title":"Exp. Mol. Med."},{"issue":"13","key":"10.1016\/j.biopha.2024.116829_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21134777","article-title":"NRF2, a Transcription factor for stress response and beyond [J]","volume":"21","author":"HE","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.116829_bib18","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.semcancer.2021.05.016","article-title":"The intricacies of NRF2 regulation in cancer [J]","volume":"76","author":"SCHMIDLIN","year":"2021","journal-title":"Semin. Cancer Biol."},{"issue":"4","key":"10.1016\/j.biopha.2024.116829_bib19","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/carcin\/bgaa039","article-title":"NRF2 as a regulator of cell metabolism and inflammation in cancer [J]","volume":"41","author":"HE","year":"2020","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.biopha.2024.116829_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114002","article-title":"Molecular mechanisms and systemic targeting of NRF2 dysregulation in cancer [J]","volume":"177","author":"KANG","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"3-4","key":"10.1016\/j.biopha.2024.116829_bib21","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10495-023-01817-5","article-title":"m6A writer WTAP targets NRF2 to accelerate bladder cancer malignancy via m6A-dependent ferroptosis regulation [J]","volume":"28","author":"WANG","year":"2023","journal-title":"Apoptosis: Int. J. Program. Cell death"},{"issue":"20","key":"10.1016\/j.biopha.2024.116829_bib22","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1101\/gad.225680.113","article-title":"The emerging role of the Nrf2-Keap1 signaling pathway in cancer [J]","volume":"27","author":"JARAMILLO","year":"2013","journal-title":"Genes Dev."},{"issue":"5","key":"10.1016\/j.biopha.2024.116829_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177549","article-title":"The NRF2 transcription factor plays a dual role in colorectal cancer: A systematic review [J]","volume":"12","author":"GONZALEZ-DONQUILES","year":"2017","journal-title":"PloS One"},{"issue":"10","key":"10.1016\/j.biopha.2024.116829_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10102668","article-title":"Nrf2 Modulation in Breast Cancer [J]","volume":"10","author":"GHAREGHOMI","year":"2022","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.biopha.2024.116829_bib25","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00122-16","article-title":"G-Quadruplex in the NRF2 mRNA 5' Untranslated Region Regulates De Novo NRF2 Protein Translation under Oxidative Stress [J]","volume":"37","author":"LEE","year":"2017","journal-title":"Mol. Cell. Biol."},{"issue":"4","key":"10.1016\/j.biopha.2024.116829_bib26","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1042\/BST20150020","article-title":"Molecular mechanisms of Nrf2 regulation and how these influence chemical modulation for disease intervention [J]","volume":"43","author":"HARDER","year":"2015","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.biopha.2024.116829_bib27","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/286524","article-title":"Genomic structure and variation of nuclear factor (erythroid-derived 2)-like 2 [J]","volume":"2013","author":"CHO","year":"2013","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"Pt B)","key":"10.1016\/j.biopha.2024.116829_bib28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.freeradbiomed.2015.05.034","article-title":"Structural basis of Keap1 interactions with Nrf2 [J]","volume":"88","author":"CANNING","year":"2015","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.biopha.2024.116829_bib29","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/onc.2012.59","article-title":"The nuclear cofactor RAC3\/AIB1\/SRC-3 enhances Nrf2 signaling by interacting with transactivation domains [J]","volume":"32","author":"KIM","year":"2013","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.biopha.2024.116829_bib30","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/bbrc.1997.6943","article-title":"An Nrf2\/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements [J]","volume":"236","author":"ITOH","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2024.116829_bib31","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1101\/gad.13.1.76","article-title":"Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain [J]","volume":"13","author":"ITOH","year":"1999","journal-title":"Genes Dev."},{"issue":"5","key":"10.1016\/j.biopha.2024.116829_bib32","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.bbamcr.2018.02.010","article-title":"Nrf2-Keap1 signaling in oxidative and reductive stress [J]","volume":"1865","author":"BELLEZZA","year":"2018","journal-title":"Biochim. Et. Biophys. Acta Mol. Cell Res."},{"issue":"17)","key":"10.1016\/j.biopha.2024.116829_bib33","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1089\/ars.2017.7342","article-title":"Transcriptional Regulation by Nrf2 [J]","volume":"29","author":"TONELLI","year":"2018","journal-title":"Antioxid. Redox Signal."},{"issue":"4","key":"10.1016\/j.biopha.2024.116829_bib34","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tibs.2014.02.002","article-title":"The Nrf2 regulatory network provides an interface between redox and intermediary metabolism [J]","volume":"39","author":"HAYES","year":"2014","journal-title":"Trends Biochem. Sci."},{"issue":"16","key":"10.1016\/j.biopha.2024.116829_bib35","doi-asserted-by":"crossref","first-page":"7130","DOI":"10.1128\/MCB.24.16.7130-7139.2004","article-title":"Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2 [J]","volume":"24","author":"KOBAYASHI","year":"2004","journal-title":"Mol. Cell. Biol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116829_bib36","doi-asserted-by":"crossref","first-page":"F662","DOI":"10.1152\/ajprenal.00421.2009","article-title":"Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure [J]","volume":"298","author":"KIM","year":"2010","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"6","key":"10.1016\/j.biopha.2024.116829_bib37","doi-asserted-by":"crossref","first-page":"538","DOI":"10.2174\/1568009617666171002144228","article-title":"Oxidative Stress and Cancer: The Role of Nrf2 [J]","volume":"18","author":"SAJADIMAJD","year":"2018","journal-title":"Curr. Cancer Drug Targets"},{"issue":"4","key":"10.1016\/j.biopha.2024.116829_bib38","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41573-018-0008-x","article-title":"Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases [J]","volume":"18","author":"CUADRADO","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"9","key":"10.1016\/j.biopha.2024.116829_bib39","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1593\/neo.11750","article-title":"NRF2 mutation confers malignant potential and resistance to chemoradiation therapy in advanced esophageal squamous cancer [J]","volume":"13","author":"SHIBATA","year":"2011","journal-title":"Neoplasia (N. Y., NY)"},{"issue":"18","key":"10.1016\/j.biopha.2024.116829_bib40","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1111\/febs.16336","article-title":"Nrf2 and oxidative stress in liver ischemia\/reperfusion injury [J]","volume":"289","author":"R","year":"2022","journal-title":"FEBS J."},{"issue":"2","key":"10.1016\/j.biopha.2024.116829_bib41","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/cvr\/cvp279","article-title":"Protection of vascular cells from oxidative stress by proteasome inhibition depends on Nrf2 [J]","volume":"85","author":"DREGER","year":"2010","journal-title":"Cardiovasc. Res."},{"issue":"11","key":"10.1016\/j.biopha.2024.116829_bib42","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.freeradbiomed.2010.09.006","article-title":"Oxidative stress, inflammation, and cancer: how are they linked? [J]","volume":"49","author":"REUTER","year":"2010","journal-title":"Free Radic. Biol. Med."},{"issue":"5930","key":"10.1016\/j.biopha.2024.116829_bib43","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation [J]","volume":"324","author":"VANDER HEIDEN","year":"2009","journal-title":"Sci. (N. Y., NY)"},{"issue":"11","key":"10.1016\/j.biopha.2024.116829_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22115938","article-title":"Sulforaphane Impact on Reactive Oxygen Species (ROS) in Bladder Carcinoma [J]","volume":"22","author":"XIE","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2024.116829_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/jcm5030029","article-title":"Preliminary Analysis of the Expression of Selected Proangiogenic and Antioxidant Genes and MicroRNAs in Patients with Non-Muscle-Invasive Bladder Cancer [J]","volume":"5","author":"KOZAKOWSKA","year":"2016","journal-title":"J. Clin. Med."},{"issue":"7","key":"10.1016\/j.biopha.2024.116829_bib46","doi-asserted-by":"crossref","first-page":"6901","DOI":"10.1007\/s13277-014-1925-x","article-title":"Urothelial carcinoma associated 1 is a hypoxia-inducible factor-1\u03b1-targeted long noncoding RNA that enhances hypoxic bladder cancer cell proliferation, migration, and invasion [J]","volume":"35","author":"XUE","year":"2014","journal-title":"Tumour Biol.: J. Int. Soc. Oncodev. Biol. Med."},{"issue":"4","key":"10.1016\/j.biopha.2024.116829_bib47","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/cas.14321","article-title":"p62 promotes bladder cancer cell growth by activating KEAP1\/NRF2-dependent antioxidative response [J]","volume":"111","author":"LI","year":"2020","journal-title":"Cancer Sci."},{"key":"10.1016\/j.biopha.2024.116829_bib48","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.taap.2018.05.022","article-title":"TRAIL attenuates sulforaphane-mediated Nrf2 and sustains ROS generation, leading to apoptosis of TRAIL-resistant human bladder cancer cells [J]","volume":"352","author":"JIN","year":"2018","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2024.116829_bib49","first-page":"1865","article-title":"Hyperforin Induces Apoptosis Through Extrinsic\/Intrinsic Pathways and Inhibits NF-\u0138B-modulated Survival and Invasion Potential in Bladder Cancer [J]","volume":"33","author":"LIU","year":"2019","journal-title":"vivo (Athens, Greece)"},{"issue":"1","key":"10.1016\/j.biopha.2024.116829_bib50","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s13046-023-02757-3","article-title":"ZEB1-mediated biogenesis of circNIPBL sustains the metastasis of bladder cancer via Wnt\/\u03b2-catenin pathway [J]","volume":"42","author":"LI","year":"2023","journal-title":"J. Exp. Clin. Cancer Res.: CR"},{"issue":"8","key":"10.1016\/j.biopha.2024.116829_bib51","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.21037\/tau-23-376","article-title":"Lobaplatin induces apoptosis in T24 and 5637 bladder cancer cells by regulating Bcl-2 and Bax expression and inhibiting the PI3K\/Akt signaling pathway [J]","volume":"12","author":"YU","year":"2023","journal-title":"Transl. Androl. Urol."},{"issue":"1-2","key":"10.1016\/j.biopha.2024.116829_bib52","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2016.12.012","article-title":"30 Years of NF-\u03baB: A Blossoming of Relevance to Human Pathobiology [J]","volume":"168","author":"ZHANG","year":"2017","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.biopha.2024.116829_bib53","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s13046-021-01935-5","article-title":"ROC1 promotes the malignant progression of bladder cancer by regulating p-I\u03baB\u03b1\/NF-\u03baB signaling [J]","volume":"40","author":"WU","year":"2021","journal-title":"J. Exp. Clin. Cancer Res.: CR"},{"issue":"5","key":"10.1016\/j.biopha.2024.116829_bib54","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1111\/cbdd.13737","article-title":"Gambogenic acid suppresses bladder cancer cells growth and metastasis by regulating NF-\u03baB signaling [J]","volume":"96","author":"ZHOU","year":"2020","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.biopha.2024.116829_bib55","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.intimp.2017.11.021","article-title":"Chlorogenic acid prevents diabetic nephropathy by inhibiting oxidative stress and inflammation through modulation of the Nrf2\/HO-1 and NF-\u0138B pathways [J]","volume":"54","author":"BAO","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2024.116829_bib56","doi-asserted-by":"crossref","first-page":"744","DOI":"10.5604\/17322693.1160361","article-title":"[The role of oxidative stress in bladder cancer] [J]","volume":"69","author":"SAWICKA","year":"2015","journal-title":"Post. Hig. i Med. doswiadczalnej (Online)"},{"key":"10.1016\/j.biopha.2024.116829_bib57","article-title":"Berbamine Suppresses the Progression of Bladder Cancer by Modulating the ROS\/NF-\u03baB Axis [J]","volume":"2021","author":"HAN","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.biopha.2024.116829_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147084","article-title":"Overexpression of Heme Oxygenase-1 Prevents Renal Interstitial Inflammation and Fibrosis Induced by Unilateral Ureter Obstruction [J]","volume":"11","author":"CHEN","year":"2016","journal-title":"PloS One"},{"issue":"7","key":"10.1016\/j.biopha.2024.116829_bib59","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/01.ibd.0000225340.99108.8a","article-title":"Gliotoxin reduces the severity of trinitrobenzene sulfonic acid-induced colitis in mice: evidence of the connection between heme oxygenase-1 and the nuclear factor-kappaB pathway in vitro and in vivo [J]","volume":"12","author":"JUN","year":"2006","journal-title":"Inflamm. bowel Dis."},{"issue":"5","key":"10.1016\/j.biopha.2024.116829_bib60","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.bbamcr.2008.01.002","article-title":"NF-kappaB\/p65 antagonizes Nrf2-ARE pathway by depriving CBP from Nrf2 and facilitating recruitment of HDAC3 to MafK [J]","volume":"1783","author":"LIU","year":"2008","journal-title":"Biochim. Et. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.biopha.2024.116829_bib61","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/nrc3458","article-title":"The Hippo pathway and human cancer [J]","volume":"13","author":"HARVEY","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"12","key":"10.1016\/j.biopha.2024.116829_bib62","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1038\/onc.2015.219","article-title":"YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage [J]","volume":"35","author":"CIAMPORCERO","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2024.116829_bib63","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.phymed.2018.10.034","article-title":"Ailanthone inhibits cell growth and migration of cisplatin resistant bladder cancer cells through down-regulation of Nrf2, YAP, and c-Myc expression [J]","volume":"56","author":"DAGA","year":"2019","journal-title":"Phytomedicine: Int. J. Phytother. Phytopharm."},{"issue":"29","key":"10.1016\/j.biopha.2024.116829_bib64","doi-asserted-by":"crossref","first-page":"27688","DOI":"10.18632\/oncotarget.4280","article-title":"FOXM1 is a downstream target of LPA and YAP oncogenic signaling pathways in high grade serous ovarian cancer [J]","volume":"6","author":"FAN","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2024.116829_bib65","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1186\/1471-2407-13-349","article-title":"Overexpression of YAP 1 contributes to progressive features and poor prognosis of human urothelial carcinoma of the bladder [J]","volume":"13","author":"LIU","year":"2013","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.biopha.2024.116829_bib66","doi-asserted-by":"crossref","first-page":"8574","DOI":"10.18632\/oncotarget.14351","article-title":"FOXM1 evokes 5-fluorouracil resistance in colorectal cancer depending on ABCC10 [J]","volume":"8","author":"XIE","year":"2017","journal-title":"Oncotarget"},{"issue":"42","key":"10.1016\/j.biopha.2024.116829_bib67","doi-asserted-by":"crossref","first-page":"68044","DOI":"10.18632\/oncotarget.11172","article-title":"Peroxiredoxin I is important for cancer-cell survival in Ras-induced hepatic tumorigenesis [J]","volume":"7","author":"HAN","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2024.116829_bib68","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.freeradbiomed.2020.02.021","article-title":"Ailanthone increases oxidative stress in CDDP-resistant ovarian and bladder cancer cells by inhibiting of Nrf2 and YAP expression through a post-translational mechanism [J]","volume":"150","author":"CUCCI","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2024.116829_bib69","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.freeradbiomed.2017.12.005","article-title":"Crosstalk between Nrf2 and YAP contributes to maintaining the antioxidant potential and chemoresistance in bladder cancer [J]","volume":"115","author":"CIAMPORCERO","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2024.116829_bib70","doi-asserted-by":"crossref","unstructured":"HA N.-H., FARAJI F., HUNTER K.W.J.C.T.D.D.A.E.D.. Mechanisms of metastasis [J]. 2013, 435-458.","DOI":"10.1007\/978-1-4614-7876-8_17"},{"issue":"3-4","key":"10.1016\/j.biopha.2024.116829_bib71","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.wneu.2011.06.063","article-title":"The role of Nrf2 in migration and invasion of human glioma cell U251 [J]","volume":"80","author":"PAN","year":"2013","journal-title":"World Neurosurg."},{"issue":"22","key":"10.1016\/j.biopha.2024.116829_bib72","doi-asserted-by":"crossref","first-page":"36603","DOI":"10.18632\/oncotarget.16622","article-title":"Suppression of radiation-induced migration of non-small cell lung cancer through inhibition of Nrf2-Notch Axis [J]","volume":"8","author":"ZHAO","year":"2017","journal-title":"Oncotarget"},{"issue":"22","key":"10.1016\/j.biopha.2024.116829_bib73","doi-asserted-by":"crossref","first-page":"9095","DOI":"10.1158\/0008-5472.CAN-10-0384","article-title":"Global downstream pathway analysis reveals a dependence of oncogenic NF-E2-related factor 2 mutation on the mTOR growth signaling pathway [J]","volume":"70","author":"SHIBATA","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2024.116829_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.626577","article-title":"Mechanisms for Modulating Anoikis Resistance in Cancer and the Relevance of Metabolic Reprogramming [J]","volume":"11","author":"ADESHAKIN","year":"2021","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.biopha.2024.116829_bib75","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/intbio\/zyz021","article-title":"NRF2 activates a partial epithelial-mesenchymal transition and is maximally present in a hybrid epithelial\/mesenchymal phenotype [J]","volume":"11","author":"BOCCI","year":"2019","journal-title":"Integr. Biol.: Quant. Biosci. Nano Macro"},{"key":"10.1016\/j.biopha.2024.116829_bib76","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.clinbiochem.2021.03.003","article-title":"Roles of matrix metalloproteinase-7 (MMP-7) in cancer [J]","volume":"92","author":"LIAO","year":"2021","journal-title":"Clin. Biochem"},{"issue":"46","key":"10.1016\/j.biopha.2024.116829_bib77","doi-asserted-by":"crossref","first-page":"19485","DOI":"10.1073\/pnas.0909228106","article-title":"Hypoxia-induced pathological angiogenesis mediates tumor cell dissemination, invasion, and metastasis in a zebrafish tumor model [J]","volume":"106","author":"LEE","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2024.116829_bib78","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2147\/HP.S93413","article-title":"The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy [J]","volume":"3","author":"MUZ","year":"2015","journal-title":"Hypoxia (Auckl., NZ)"},{"issue":"4","key":"10.1016\/j.biopha.2024.116829_bib79","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.3892\/or.2013.2278","article-title":"Reactive oxygen species regulate FSH-induced expression of vascular endothelial growth factor via Nrf2 and HIF1\u03b1 signaling in human epithelial ovarian cancer [J]","volume":"29","author":"ZHANG","year":"2013","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biopha.2024.116829_bib80","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev-pharmtox-011112-140320","article-title":"Role of nrf2 in oxidative stress and toxicity [J]","volume":"53","author":"MA","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"24","key":"10.1016\/j.biopha.2024.116829_bib81","first-page":"312","article-title":"Regulation of Nrf2 Signaling [J]","volume":"8","author":"LI","year":"2019","journal-title":"React. Oxyg. Species (Apex, NC)"},{"issue":"6","key":"10.1016\/j.biopha.2024.116829_bib82","first-page":"904","article-title":"SHCBP1 Is a Prognostic Biomarker Related to the Tumour Immune Microenvironment in Pan-Cancer [J]","volume":"52","author":"HUANG","year":"2022","journal-title":"Ann. Clin. Lab. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2024.116829_bib83","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.3892\/or.2015.4214","article-title":"Aberrantly elevated redox sensing factor Nrf2 promotes cancer stem cell survival via enhanced transcriptional regulation of ABCG2 and Bcl-2\/Bmi-1 genes [J]","volume":"34","author":"JIA","year":"2015","journal-title":"Oncol. Rep."},{"issue":"10","key":"10.1016\/j.biopha.2024.116829_bib84","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1002\/stem.1764","article-title":"Nrf2, a regulator of the proteasome, controls self-renewal and pluripotency in human embryonic stem cells [J]","volume":"32","author":"JANG","year":"2014","journal-title":"Stem Cells (Dayt., Ohio)"},{"issue":"2","key":"10.1016\/j.biopha.2024.116829_bib85","doi-asserted-by":"crossref","first-page":"111","DOI":"10.15430\/JCP.2014.19.2.111","article-title":"Targeting nrf2 signaling to combat chemoresistance [J]","volume":"19","author":"NO","year":"2014","journal-title":"J. Cancer Prev."},{"issue":"11","key":"10.1016\/j.biopha.2024.116829_bib86","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11111755","article-title":"The Role of Nrf2 Activity in Cancer Development and Progression [J]","volume":"11","author":"ZIMTA","year":"2019","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.biopha.2024.116829_bib87","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.urolonc.2014.02.006","article-title":"The Nrf2 transcription factor contributes to resistance to cisplatin in bladder cancer [J]","volume":"32","author":"HAYDEN","year":"2014","journal-title":"Urol. Oncol."},{"issue":"6","key":"10.1016\/j.biopha.2024.116829_bib88","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/mc.22615","article-title":"ABCF2, an Nrf2 target gene, contributes to cisplatin resistance in ovarian cancer cells [J]","volume":"56","author":"BAO","year":"2017","journal-title":"Mol. Carcinog."},{"issue":"10","key":"10.1016\/j.biopha.2024.116829_bib89","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030420","article-title":"Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer [J]","volume":"3","author":"SINGH","year":"2006","journal-title":"PLoS Med."},{"issue":"6","key":"10.1016\/j.biopha.2024.116829_bib90","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/carcin\/bgn095","article-title":"Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2 [J]","volume":"29","author":"WANG","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.biopha.2024.116829_bib91","doi-asserted-by":"crossref","unstructured":"CRABB S.J., WHEATER M.J.C.D.T.. Advances in chemotherapy and targeted systemic therapies for urothelial cancer [J]. 2010, 5(1): 17-28.","DOI":"10.2174\/1574885511005010017"},{"key":"10.1016\/j.biopha.2024.116829_bib92","doi-asserted-by":"crossref","first-page":"6079","DOI":"10.2147\/CMAR.S200998","article-title":"Transcription factor Nrf2 induces the up-regulation of lncRNA TUG1 to promote progression and adriamycin resistance in urothelial carcinoma of the bladder [J]","volume":"11","author":"SUN","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.biopha.2024.116829_bib93","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13616","article-title":"Targeting the Notch-regulated non-coding RNA TUG1 for glioma treatment [J]","volume":"7","author":"KATSUSHIMA","year":"2016","journal-title":"Nat. Commun."},{"issue":"51","key":"10.1016\/j.biopha.2024.116829_bib94","doi-asserted-by":"crossref","first-page":"88689","DOI":"10.18632\/oncotarget.20927","article-title":"Knockdown of long non-coding RNA Taurine Up-Regulated 1 inhibited doxorubicin resistance of bladder urothelial carcinoma via Wnt\/\u03b2-catenin pathway [J]","volume":"8","author":"XIE","year":"2017","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.biopha.2024.116829_bib95","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1002\/tox.23796","article-title":"NEDD4L inhibits migration, invasion, cisplatin resistance and promotes apoptosis of bladder cancer cells by inactivating the p62\/Keap1\/Nrf2 pathway [J]","volume":"38","author":"WU","year":"2023","journal-title":"Environ. Toxicol."},{"issue":"10","key":"10.1016\/j.biopha.2024.116829_bib96","first-page":"11178","article-title":"Bladder cancer cells prevent cisplatin-induced oxidative stress by upregulating Nestin1 expression [J]","volume":"13","author":"ZHANG","year":"2021","journal-title":"Am. J. Transl. Res."},{"issue":"1","key":"10.1016\/j.biopha.2024.116829_bib97","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/nm.4232","article-title":"Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth [J]","volume":"23","author":"CRAMER","year":"2017","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.biopha.2024.116829_bib98","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1083\/jcb.201804161","article-title":"Glutathione metabolism in cancer progression and treatment resistance [J]","volume":"217","author":"BANSAL","year":"2018","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.biopha.2024.116829_bib99","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.canlet.2021.03.030","article-title":"Jolkinolide B targets thioredoxin and glutathione systems to induce ROS-mediated paraptosis and apoptosis in bladder cancer cells [J]","volume":"509","author":"SANG","year":"2021","journal-title":"Cancer Lett."},{"issue":"8","key":"10.1016\/j.biopha.2024.116829_bib100","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24087608","article-title":"MTX-211 Inhibits GSH Synthesis through Keap1\/NRF2\/GCLM Axis and Exerts Antitumor Effects in Bladder Cancer [J]","volume":"24","author":"HU","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2024.116829_bib101","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.bmcl.2012.11.116","article-title":"Cytotoxic quassinoids from Ailanthus altissima [J]","volume":"23","author":"WANG","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"15","key":"10.1016\/j.biopha.2024.116829_bib102","first-page":"55","article-title":"Ailanthone reverses multidrug resistance by inhibiting the P-glycoprotein-mediated efflux in resistant K562\/A02 cells [J]","volume":"64","author":"HAN","year":"2018","journal-title":"Cell. Mol. Biol. (Noisy-Le. -Gd., Fr. )"},{"key":"10.1016\/j.biopha.2024.116829_bib103","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.13402","article-title":"Down-regulated NEDD4L facilitates tumor progression through activating Notch signaling in lung adenocarcinoma [J]","volume":"10","author":"LIN","year":"2022","journal-title":"PeerJ"},{"issue":"19","key":"10.1016\/j.biopha.2024.116829_bib104","doi-asserted-by":"crossref","first-page":"5530","DOI":"10.1111\/febs.15637","article-title":"The multifaceted role of TRAIL signaling in cancer and immunity [J]","volume":"288","author":"CARDOSO ALVES","year":"2021","journal-title":"FEBS J."},{"key":"10.1016\/j.biopha.2024.116829_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111692","article-title":"Piezo-type mechanosensitive ion channel component 1 (Piezo1) in human cancer [J]","volume":"140","author":"YU","year":"2021","journal-title":"Biomed. Pharm."},{"issue":"4","key":"10.1016\/j.biopha.2024.116829_bib106","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.neurobiolaging.2010.06.006","article-title":"Engulfment adapter PTB domain containing 1 interacts with and affects processing of the amyloid-\u03b2 precursor protein [J]","volume":"33","author":"BEYER","year":"2012","journal-title":"Neurobiol. Aging"},{"issue":"645","key":"10.1016\/j.biopha.2024.116829_bib107","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aba0443","article-title":"GULP1 regulates the NRF2-KEAP1 signaling axis in urothelial carcinoma [J]","volume":"13","author":"HAYASHI","year":"2020","journal-title":"Sci. Signal."},{"issue":"4","key":"10.1016\/j.biopha.2024.116829_bib108","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1111\/cas.13963","article-title":"Prothymosin-\u03b1 enhances phosphatase and tensin homolog expression and binds with tripartite motif-containing protein 21 to regulate Kelch-like ECH-associated protein 1\/nuclear factor erythroid 2-related factor 2 signaling in human bladder cancer [J]","volume":"110","author":"TSAI","year":"2019","journal-title":"Cancer Sci."},{"issue":"2","key":"10.1016\/j.biopha.2024.116829_bib109","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.canlet.2013.01.033","article-title":"Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression [J]","volume":"333","author":"LUO","year":"2013","journal-title":"Cancer Lett."},{"issue":"13","key":"10.1016\/j.biopha.2024.116829_bib110","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/j.febslet.2008.05.012","article-title":"UCA1, a non-protein-coding RNA up-regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion [J]","volume":"582","author":"WANG","year":"2008","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.biopha.2024.116829_bib111","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1042\/BST20110641","article-title":"Exploring the function of the JNK (c-Jun N-terminal kinase) signalling pathway in physiological and pathological processes to design novel therapeutic strategies [J]","volume":"40","author":"DAVIES","year":"2012","journal-title":"Biochem. Soc. Trans."},{"issue":"2","key":"10.1016\/j.biopha.2024.116829_bib112","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.18632\/oncotarget.2833","article-title":"Knockdown of a novel lincRNA AATBC suppresses proliferation and induces apoptosis in bladder cancer [J]","volume":"6","author":"ZHAO","year":"2015","journal-title":"Oncotarget"},{"issue":"52","key":"10.1016\/j.biopha.2024.116829_bib113","doi-asserted-by":"crossref","first-page":"39776","DOI":"10.1074\/jbc.M605707200","article-title":"p53 suppresses the Nrf2-dependent transcription of antioxidant response genes [J]","volume":"281","author":"FARAONIO","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2024.116829_bib114","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1158\/0008-5472.CAN-07-2170","article-title":"Activating transcription factor 3 is a novel repressor of the nuclear factor erythroid-derived 2-related factor 2 (Nrf2)-regulated stress pathway [J]","volume":"68","author":"BROWN","year":"2008","journal-title":"Cancer Res."},{"issue":"Pt 5","key":"10.1016\/j.biopha.2024.116829_bib115","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1242\/jcs.095422","article-title":"E-cadherin inhibits nuclear accumulation of Nrf2: implications for chemoresistance of cancer cells [J]","volume":"125","author":"KIM","year":"2012","journal-title":"J. Cell Sci."},{"issue":"25","key":"10.1016\/j.biopha.2024.116829_bib116","doi-asserted-by":"crossref","first-page":"20922","DOI":"10.1074\/jbc.M112.352336","article-title":"Caveolin-1 inhibits expression of antioxidant enzymes through direct interaction with nuclear erythroid 2 p45-related factor-2 (Nrf2) [J]","volume":"287","author":"LI","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"32","key":"10.1016\/j.biopha.2024.116829_bib117","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1038\/onc.2012.388","article-title":"Nrf2 is controlled by two distinct \u03b2-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity [J]","volume":"32","author":"CHOWDHRY","year":"2013","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.biopha.2024.116829_bib118","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.exphem.2004.01.007","article-title":"Ascorbic acid restores sensitivity to imatinib via suppression of Nrf2-dependent gene expression in the imatinib-resistant cell line [J]","volume":"32","author":"TARUMOTO","year":"2004","journal-title":"Exp. Hematol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116829_bib119","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1159\/000430398","article-title":"Cryptotanshinone Reverses Cisplatin Resistance of Human Lung Carcinoma A549 Cells through Down-Regulating Nrf2 Pathway [J]","volume":"37","author":"XIA","year":"2015","journal-title":"Cell. Physiol. Biochem.: Int. J. Exp. Cell. Physiol., Biochem., Pharmacol."},{"issue":"13","key":"10.1016\/j.biopha.2024.116829_bib120","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.7314\/APJCP.2014.15.13.5311","article-title":"Luteolin-loaded phytosomes sensitize human breast carcinoma MDA-MB 231 cells to doxorubicin by suppressing Nrf2 mediated signalling [J]","volume":"15","author":"SABZICHI","year":"2014","journal-title":"Asian Pac. J. Cancer Prev.: APJCP"},{"issue":"9-10","key":"10.1016\/j.biopha.2024.116829_bib121","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1080\/1061186X.2017.1363215","article-title":"The AGMA1 polyamidoamine mediates the efficient delivery of siRNA [J]","volume":"25","author":"CAVALLI","year":"2017","journal-title":"J. Drug Target."},{"issue":"3","key":"10.1016\/j.biopha.2024.116829_bib122","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1089\/nat.2020.0862","article-title":"Chitosan-Shelled Nanobubbles Irreversibly Encapsulate Morpholino Conjugate Antisense Oligonucleotides and Are Ineffective for Phosphorodiamidate Morpholino-Mediated Gene Silencing of DUX4 [J]","volume":"31","author":"FALZARANO","year":"2021","journal-title":"Nucleic Acid. Ther."},{"issue":"2","key":"10.1016\/j.biopha.2024.116829_bib123","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4155\/tde.15.92","article-title":"Nanobubbles: a promising efficient tool for therapeutic delivery [J]","volume":"7","author":"CAVALLI","year":"2016","journal-title":"Ther. Deliv."},{"issue":"2","key":"10.1016\/j.biopha.2024.116829_bib124","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2174\/1566523217666170510160527","article-title":"Delivering siRNA with Dendrimers: In Vivo Applications [J]","volume":"17","author":"LEIRO","year":"2017","journal-title":"Curr. Gene Ther."},{"issue":"10","key":"10.1016\/j.biopha.2024.116829_bib125","article-title":"Carbosilane Dendrimers Loaded with siRNA Targeting Nrf2 as a Tool to Overcome Cisplatin Chemoresistance in Bladder Cancer Cells [J]","volume":"9","author":"AMBROSIO","year":"2020","journal-title":"Antioxid. (Basel, Switz. )"},{"issue":"1","key":"10.1016\/j.biopha.2024.116829_bib126","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","article-title":"Targeting PI3K\/Akt signal transduction for cancer therapy [J]","volume":"6","author":"HE","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.biopha.2024.116829_bib127","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13122","article-title":"Ailanthone targets p23 to overcome MDV3100 resistance in castration-resistant prostate cancer [J]","volume":"7","author":"HE","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2024.116829_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105575","article-title":"Nrf2 signaling pathway in cisplatin chemotherapy: Potential involvement in organ protection and chemoresistance [J]","volume":"167","author":"MIRZAEI","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"11","key":"10.1016\/j.biopha.2024.116829_bib129","first-page":"2043","article-title":"[Synergism inhibition of curcumin combined with cisplatin on T24 bladder carcinoma cells and its related mechanism] [J]","volume":"37","author":"ZHANG","year":"2014","journal-title":"Zhong yao cai = Zhongyaocai = J. Chin. Med. Mater."},{"issue":"12","key":"10.1016\/j.biopha.2024.116829_bib130","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nrc2288","article-title":"Innovations in image-guided radiotherapy [J]","volume":"7","author":"VERELLEN","year":"2007","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2024.116829_bib131","first-page":"175","article-title":"In vitro anticancer activity of PI3K alpha selective inhibitor BYL719 in head and neck cancer [J]","volume":"35","author":"KEAM","year":"2015","journal-title":"Anticancer Res."},{"issue":"7","key":"10.1016\/j.biopha.2024.116829_bib132","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1245\/s10434-014-3600-2","article-title":"Nrf2 is useful for predicting the effect of chemoradiation therapy on esophageal squamous cell carcinoma [J]","volume":"21","author":"KAWASAKI","year":"2014","journal-title":"Ann. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116829_bib133","doi-asserted-by":"crossref","DOI":"10.1177\/15593258211033114","article-title":"Diallyl Disulfide Attenuates Ionizing Radiation-Induced Migration and Invasion by Suppressing Nrf2 Signaling in Non-small-Cell Lung Cancer [J]","volume":"19","author":"XU","year":"2021","journal-title":"Dose-Response.: a Publ. Int. Hormesis Soc."},{"issue":"1","key":"10.1016\/j.biopha.2024.116829_bib134","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"Oncology meets immunology: the cancer-immunity cycle [J]","volume":"39","author":"CHEN","year":"2013","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.biopha.2024.116829_bib135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124959","article-title":"Construction of a BALB\/c-Nu Mouse Model of Invasive Bladder Carcinoma and Preliminary Studies on the Treatment of Bladder Tumors through Internal Iliac Arterial Infusion of Albumin-Bound Arsenic Trioxide (As2O3) [J]","volume":"10","author":"LI","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.biopha.2024.116829_bib136","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/181987","article-title":"Bladder Cancer Immunotherapy: BCG and Beyond [J]","volume":"2012","author":"ASKELAND","year":"2012","journal-title":"Adv. Urol."},{"key":"10.1016\/j.biopha.2024.116829_bib137","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.biopha.2018.08.057","article-title":"Additive antitumor effect of arsenic trioxide combined with intravesical bacillus Calmette-Guerin immunotherapy against bladder cancer through blockade of the IER3\/Nrf2 pathway [J]","volume":"107","author":"MAO","year":"2018","journal-title":"Biomed. Pharm."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224007133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224007133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:41:32Z","timestamp":1781649692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224007133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":137,"alternative-id":["S0753332224007133"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116829","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting Nrf2 signaling pathways in the role of bladder cancer: From signal network to targeted therapy","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116829","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116829"}}